Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Luisa Mestroni to Genetic Predisposition to Disease

This is a "connection" page, showing publications Luisa Mestroni has written about Genetic Predisposition to Disease.

 
Connection Strength
 
 
 
1.563
 
  1. Gigli M, Stolfo D, Graw SL, Merlo M, Gregorio C, Nee Chen S, Dal Ferro M, PaldinoMD A, De Angelis G, Brun F, Jirikowic J, Salcedo EE, Turja S, Fatkin D, Johnson R, van Tintelen JP, Te Riele ASJM, Wilde AAM, Lakdawala NK, Picard K, Miani D, Muser D, Maria Severini G, Calkins H, James CA, Murray B, Tichnell C, Parikh VN, Ashley EA, Reuter C, Song J, Judge DP, McKenna WJ, Taylor MRG, Sinagra G, Mestroni L. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants. Circulation. 2021 11 16; 144(20):1600-1611.
    View in: PubMed
    Score: 0.377
  2. Mestroni L, Taylor MR. Hearing the noise the challenges of human genome variation in genetic testing. J Am Coll Cardiol. 2011 Jun 07; 57(23):2328-9.
    View in: PubMed
    Score: 0.184
  3. Stroeks SLVM, Bart NK, Rossano J, Claggett B, Beelen NJ, Buchan RJ, Day S, Fornaro A, Halliday BP, Wheeler MT, Hammersley DJ, Helms A, Heymans ABM, Ho CY, Khan SS, Lin K, Lota A, Merlo M, Mestroni L, Olivotto I, Owens A, Seidman CE, Shore S, Sinnette C, Sinagra G, Stevenson LW, Stewart GC, Theotakis P, Venner MFGHM, Ware JS, Taylor MRG, Verdonschot JAJ, Wilsbacher L, Prasad S, Heymans SR, Parikh VN, Tayal U, Lakdawala NK. Sex and Age Specific Genetic Risk Across the Dilated and Arrhythmogenic Cardiomyopathy Spectrum: Insights From the SHaRe Registry. J Am Coll Cardiol. 2026 Jun 30; 87(25):3573-3588.
    View in: PubMed
    Score: 0.130
  4. Gigli M, Stolfo D, Merlo M, Sinagra G, Taylor MRG, Mestroni L. Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine. Nat Rev Cardiol. 2025 03; 22(3):183-198.
    View in: PubMed
    Score: 0.116
  5. Brun F, Gigli M, Graw SL, Judge DP, Merlo M, Murray B, Calkins H, Sinagra G, Taylor MR, Mestroni L, James CA. FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy. J Med Genet. 2020 04; 57(4):254-257.
    View in: PubMed
    Score: 0.084
  6. McNally EM, Mestroni L. Dilated Cardiomyopathy: Genetic Determinants and Mechanisms. Circ Res. 2017 Sep 15; 121(7):731-748.
    View in: PubMed
    Score: 0.071
  7. Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ. The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. JAMA Cardiol. 2017 04 01; 2(4):419-428.
    View in: PubMed
    Score: 0.069
  8. Miani D, Taylor M, Mestroni L, D'Aurizio F, Finato N, Fanin M, Brigido S, Proclemer A. Sudden death associated with danon disease in women. Am J Cardiol. 2012 Feb 01; 109(3):406-11.
    View in: PubMed
    Score: 0.047
  9. Mestroni L, Merlo M, Taylor MR, Camerini F, Sinagra G. Heart failure and personalized medicine. J Cardiovasc Med (Hagerstown). 2011 Jan; 12(1):6-12.
    View in: PubMed
    Score: 0.045
  10. Mestroni L. Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss? J Am Coll Cardiol. 2009 Jul 21; 54(4):343-5.
    View in: PubMed
    Score: 0.040
  11. Floyd BJ, Njoroge JN, Krysov VA, Gomes B, Murtha R, Aribeana C, Cannie D, Smith E, Paldino A, Brown EE, Barth A, Ilhan E, Johnson R, Wojciak J, Alkhayat M, Graw S, Medo K, Haas J, Chahal CAA, Fenzl K, Steinmetz L, Gollob M, Ashley E, Day S, Judge D, Roberts JD, Vedantham V, Mao CY, Fatkin D, Lakdawala NK, Taylor MRG, Mestroni L, Saguner AM, Tayal U, Cadrin-Tourigny J, Krahn AD, James C, Dal Ferro M, Sinagra G, Merlo M, Owens A, Reza N, Saberi S, Helms A, Elliott P, Meder B, Lancaster M, Parikh VN. RBM20 Truncating Variants and Human Cardiomyopathy. JAMA Cardiol. 2026 May 01; 11(5):439-445.
    View in: PubMed
    Score: 0.032
  12. Taylor MR, Slavov D, Gajewski A, Vlcek S, Ku L, Fain PR, Carniel E, Di Lenarda A, Sinagra G, Boucek MM, Cavanaugh J, Graw SL, Ruegg P, Feiger J, Zhu X, Ferguson DA, Bristow MR, Gotzmann J, Foisner R, Mestroni L. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat. 2005 Dec; 26(6):566-74.
    View in: PubMed
    Score: 0.031
  13. Stroeks SLVM, Merlo M, Mora-Ayestaran N, Jason M, Tayal U, Wang P, Cannatà A, Sikking MA, Dal Ferro M, Peiro B, Willemars M, Hellebrekers DMEI, van Leeuwen REW, Setti M, Gonzalez-Lopez E, Krapels IPC, Pio Loco Detto Gava C, van den Wijngaard A, Henkens MTHM, Iseppi M, Raafs AG, Hoes MF, van Empel VPM, Jones EAV, Nabben M, Taylor M, Brunner HG, Ochoa JP, Dominguez F, Lakdawala NK, Sinagra G, Garcia-Pavia P, Mestroni L, Heymans SRB, Verdonschot JAJ. Sex Differences in Prognosis of Patients With Genetic Dilated Cardiomyopathy. Circ Heart Fail. 2025 Nov; 18(11):e012592.
    View in: PubMed
    Score: 0.031
  14. Pitsava G, Hawley M, Auriga L, de Dios I, Ko A, Marmolejos S, Almalvez M, Chen I, Scozzaro K, Zhao J, Barrick R, Ah Mew N, Fusaro VA, LoTempio J, Taylor M, Mestroni L, Graw S, Milewicz D, Guo D, Murdock DR, Bujakowska KM, Xiao C, Délot EC, Berger SI, Vilain E. Genome sequencing reveals the impact of pseudoexons in rare genetic disease. Genet Med. 2025 Nov; 27(11):101574.
    View in: PubMed
    Score: 0.031
  15. Savonitto G, Paldino A, Setti M, Furlan S, Tavcar I, Ribichini FL, Perotto M, Gigli M, Mestroni L, Dal Ferro M, Merlo M, Sinagra G. Prognostic role of exercise intensity in familial Filamin C truncating variants. Open Heart. 2025 Aug 27; 12(2).
    View in: PubMed
    Score: 0.031
  16. Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Bundgaard H, Orav EJ, Ho CY. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1083-1088.
    View in: PubMed
    Score: 0.027
  17. Ku L, Feiger J, Taylor M, Mestroni L. Cardiology patient page. Familial dilated cardiomyopathy. Circulation. 2003 Oct 28; 108(17):e118-21.
    View in: PubMed
    Score: 0.027
  18. Taylor MR, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WL, Stetler GL, Muntoni F, Bristow MR, Mestroni L. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol. 2003 Mar 05; 41(5):771-80.
    View in: PubMed
    Score: 0.026
  19. Axelsson Raja A, Shi L, Day SM, Russell M, Zahka K, Lever H, Colan SD, Margossian R, Hall EK, Becker J, Jefferies JL, Patel AR, Choudhury L, Murphy AM, Canter C, Bach R, Taylor M, Mestroni L, Wheeler MT, Benson L, Owens AT, Rossano J, Lin KY, Pahl E, Pereira AC, Bundgaard H, Lewis GD, Vargas JD, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Orav EJ, Braunwald E, Ho CY. Baseline Characteristics of the VANISH Cohort. Circ Heart Fail. 2019 12; 12(12):e006231.
    View in: PubMed
    Score: 0.021
  20. Paldino A, De Angelis G, Merlo M, Gigli M, Dal Ferro M, Severini GM, Mestroni L, Sinagra G. Genetics of Dilated Cardiomyopathy: Clinical Implications. Curr Cardiol Rep. 2018 08 13; 20(10):83.
    View in: PubMed
    Score: 0.019
  21. Laurini E, Martinelli V, Lanzicher T, Puzzi L, Borin D, Chen SN, Long CS, Lee P, Mestroni L, Taylor MRG, Sbaizero O, Pricl S. Biomechanical defects and rescue of cardiomyocytes expressing pathologic nuclear lamins. Cardiovasc Res. 2018 05 01; 114(6):846-857.
    View in: PubMed
    Score: 0.019
  22. Dal Ferro M, Stolfo D, Altinier A, Gigli M, Perrieri M, Ramani F, Barbati G, Pivetta A, Brun F, Monserrat L, Giacca M, Mestroni L, Merlo M, Sinagra G. Association between mutation status and left ventricular reverse remodelling in dilated cardiomyopathy. Heart. 2017 11; 103(21):1704-1710.
    View in: PubMed
    Score: 0.017
  23. Te Riele AS, Agullo-Pascual E, James CA, Leo-Macias A, Cerrone M, Zhang M, Lin X, Lin B, Sobreira NL, Amat-Alarcon N, Marsman RF, Murray B, Tichnell C, van der Heijden JF, Dooijes D, van Veen TA, Tandri H, Fowler SJ, Hauer RN, Tomaselli G, van den Berg MP, Taylor MR, Brun F, Sinagra G, Wilde AA, Mestroni L, Bezzina CR, Calkins H, Peter van Tintelen J, Bu L, Delmar M, Judge DP. Multilevel analyses of SCN5A mutations in arrhythmogenic right ventricular dysplasia/cardiomyopathy suggest non-canonical mechanisms for disease pathogenesis. Cardiovasc Res. 2017 01; 113(1):102-111.
    View in: PubMed
    Score: 0.017
  24. Begay RL, Graw S, Sinagra G, Merlo M, Slavov D, Gowan K, Jones KL, Barbati G, Spezzacatene A, Brun F, Di Lenarda A, Smith JE, Granzier HL, Mestroni L, Taylor M. Role of Titin Missense Variants in Dilated Cardiomyopathy. J Am Heart Assoc. 2015 Nov 13; 4(11).
    View in: PubMed
    Score: 0.016
  25. Brun F, Mestroni L, Sinagra G. [Molecular genetic testing according to the latest European guidelines on hypertrophic cardiomyopathy]. G Ital Cardiol (Rome). 2015 Mar; 16(3):138-42.
    View in: PubMed
    Score: 0.015
  26. D'souza RS, Levandowski C, Slavov D, Graw SL, Allen LA, Adler E, Mestroni L, Taylor MR. Danon disease: clinical features, evaluation, and management. Circ Heart Fail. 2014 Sep; 7(5):843-9.
    View in: PubMed
    Score: 0.014
  27. Merlo M, Sinagra G, Carniel E, Slavov D, Zhu X, Barbati G, Spezzacatene A, Ramani F, Salcedo E, Di Lenarda A, Mestroni L, Taylor MR. Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. Clin Transl Sci. 2013 Dec; 6(6):424-8.
    View in: PubMed
    Score: 0.014
  28. Bortot B, Athanasakis E, Brun F, Rizzotti D, Mestroni L, Sinagra G, Severini GM. High-throughput genotyping robot-assisted method for mutation detection in patients with hypertrophic cardiomyopathy. Diagn Mol Pathol. 2011 Sep; 20(3):175-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)